Lundbeck Pharmaceuticals LLC drugs

6 results
  • northera

    (droxidopa)
    Lundbeck Pharmaceuticals LLC
    NORTHERA is indicated for treating orthostatic dizziness and lightheadedness in adults with symptomatic neurogenic orthostatic hypotension due to conditions like Parkinson's disease, multiple system atrophy, and autonomic neuropathy. Its effectiveness beyond two weeks is not established and should be assessed periodically.
  • sabril

    (vigabatrin)
    Lundbeck Pharmaceuticals LLC
    SABRIL is indicated as adjunctive therapy for adults and pediatric patients (2 years and older) with refractory complex partial seizures and as monotherapy for pediatric patients (1 month to 2 years) with infantile spasms. Both uses consider the potential benefits versus the risk of vision loss.
  • sabril

    (vigabatrin)
    Lundbeck Pharmaceuticals LLC
    SABRIL is indicated as adjunctive therapy for refractory complex partial seizures in patients aged 2 and older who have not responded to other treatments, and as monotherapy for infantile spasms in pediatric patients aged 1 month to 2 years, weighing the potential benefits against the risk of vision loss.